Holbein B[au] - Search Results

Year	Number of Results
1976	1
1977	1
1979	3
1980	1
1981	4
1983	3
1984	4
1985	2
2002	2
2006	1
2007	3
2008	1
2010	2
2011	1
2015	4
2016	1
2017	2
2018	5
2019	5
2020	5
2021	4
2022	4
2023	3
2024	0

1

Iron should be restricted in acute infection.

Scott CR, Holbein BE, Lehmann CD. Scott CR, et al. Among authors: holbein be. Front Biosci (Landmark Ed). 2020 Jan 1;25(4):673-682. doi: 10.2741/4827. Front Biosci (Landmark Ed). 2020. PMID: 31585910 Free article. Review.

2

Iron Chelation as a Potential Therapeutic Approach in Acute Lung Injury.

Zhang X, Zhou J, Holbein BE, Lehmann C. Zhang X, et al. Among authors: holbein be. Life (Basel). 2023 Jul 30;13(8):1659. doi: 10.3390/life13081659. Life (Basel). 2023. PMID: 37629516 Free PMC article. Review.

3

Dysregulated Iron Homeostasis as Common Disease Etiology and Promising Therapeutic Target.

Holbein BE, Lehmann C. Holbein BE, et al. Antioxidants (Basel). 2023 Mar 9;12(3):671. doi: 10.3390/antiox12030671. Antioxidants (Basel). 2023. PMID: 36978919 Free PMC article. Review.

4

The utility of iron chelators in the management of inflammatory disorders.

Lehmann C, Islam S, Jarosch S, Zhou J, Hoskin D, Greenshields A, Al-Banna N, Sharawy N, Sczcesniak A, Kelly M, Wafa K, Cheliak W, Holbein B. Lehmann C, et al. Among authors: holbein b. Mediators Inflamm. 2015;2015:516740. doi: 10.1155/2015/516740. Epub 2015 Mar 23. Mediators Inflamm. 2015. PMID: 25878400 Free PMC article. Review.

5

Iron chelation for the treatment of uveitis.

Chen J, Zhou J, Kelly M, Holbein BE, Lehmann C. Chen J, et al. Among authors: holbein be. Med Hypotheses. 2017 Jun;103:1-4. doi: 10.1016/j.mehy.2017.03.029. Epub 2017 Mar 30. Med Hypotheses. 2017. PMID: 28571790

6

Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.

Holbein BE, Ang MTC, Allan DS, Chen W, Lehmann C. Holbein BE, et al. Environ Chem Lett. 2021;19(4):2789-2808. doi: 10.1007/s10311-021-01242-7. Epub 2021 Apr 23. Environ Chem Lett. 2021. PMID: 33907538 Free PMC article. Review.

7

Iron Chelation as Novel Treatment for Interstitial Cystitis.

Hagn G, Westhofen R, Burkovskiy I, Holbein B, Zhou J, Lehmann C. Hagn G, et al. Among authors: holbein b. Pharmacology. 2019;103(3-4):159-162. doi: 10.1159/000496089. Epub 2019 Jan 29. Pharmacology. 2019. PMID: 30695781

8

Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in Staphylococcus aureus.

Allan DS, Holbein BE. Allan DS, et al. Among authors: holbein be. Antibiotics (Basel). 2022 Nov 17;11(11):1642. doi: 10.3390/antibiotics11111642. Antibiotics (Basel). 2022. PMID: 36421286 Free PMC article.

9

Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury.

Lehmann C, Alizadeh-Tabrizi N, Hall S, Faridi S, Euodia I, Holbein B, Zhou J, Chappe V. Lehmann C, et al. Among authors: holbein b. Molecules. 2022 Jun 23;27(13):4036. doi: 10.3390/molecules27134036. Molecules. 2022. PMID: 35807282 Free PMC article.

10

Iron Withdrawal with DIBI, a Novel 3-Hydroxypyridin-4-One Chelator Iron-Binding Polymer, Attenuates Macrophage Inflammatory Responses.

Ghassemi-Rad J, Fernando W, Holbein BE, Hoskin DW. Ghassemi-Rad J, et al. Among authors: holbein be. Adv Pharm Bull. 2023 Mar;13(2):368-377. doi: 10.34172/apb.2023.040. Epub 2022 Jan 2. Adv Pharm Bull. 2023. PMID: 37342371 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year